The private placement includes participation from several leading healthcare investors including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management and Nazare Partners Proceeds expected to e

Cohen & Steers, Inc. Declares Quarterly Dividend

04:20pm, Thursday, 30'th Apr 2026
NEW YORK, April 30, 2026 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the second quarter of 2026 in the amount of $0.67 per share of common s
/PRNewswire/ -- Cohen and Steers, Inc. (NYSE: CNS) a annoncé aujourd'hui qu'elle avait changé le nom de deux de ses fonds SICAV afin de mieux refléter les
/PRNewswire/ -- Cohen and Steers, Inc. (NYSE: CNS) announced today that it has changed the name of two of its SICAV funds to better align with market definitions
NEW YORK, April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of
NEW YORK, April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dis
NEW YORK, April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the s
NEW YORK, April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
NEW YORK, April 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc.  (NYSE: FOF) (the "Fund") with information regarding the sources
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in
- Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier -
- Late-breaking oral presentation: IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month GLP toxicology study in NHPs -
BLUF: RQI delivers 8.93% annualized distribution yield through a leveraged REIT portfolio — but the structure beneath that yield includes a 30% leverage layer, floating-rate exposure on 19% of borro
Brian W. Heller to succeed Mr. Poli in 2027 NEW YORK, April 27, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today announced that Francis C.
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 20, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE